Immunology of Chlamydia infection:: Implications for a Chlamydia trachomatis vaccine

被引:454
作者
Brunham, RC [1 ]
Rey-Ladino, J [1 ]
机构
[1] Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 4R4, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1038/nri1551
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sexually transmitted Chlamydia trachomatis infections are a serious public-health problem. With more than 90 million new cases occurring annually, C. trachomatis is the most common cause of bacterial sexually transmitted disease worldwide. Recent progress in elucidating the immunobiology of Chlamydia muridarum infection of mice has helped to guide the interpretation of immunological findings in studies of human C. trachomatis infection and has led to the development of a common model of immunity. In this review, we describe our current understanding of the immune response to infection with Chlamydia spp. and how this information is improving the prospects for development of a vaccine against infection with C. trachomatis.
引用
收藏
页码:149 / 161
页数:13
相关论文
共 144 条
[41]  
HASSELL AB, 1993, IMMUNOLOGY, V79, P513
[42]   A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa [J].
Hawkins, RA ;
Rank, RG ;
Kelly, KA .
INFECTION AND IMMUNITY, 2002, 70 (09) :5132-5139
[43]   Steroid receptor expression in uterine natural killer cells [J].
Henderson, TA ;
Saunders, PTK ;
Moffett-King, A ;
Groome, NP ;
Critchley, HOD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :440-449
[44]   Chlamydial persistence: beyond the biphasic paradigm [J].
Hogan, RJ ;
Mathews, SA ;
Mukhopadhyay, S ;
Summersgill, JT ;
Timms, P .
INFECTION AND IMMUNITY, 2004, 72 (04) :1843-1855
[45]   The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass [J].
Högbom, M ;
Stenmark, P ;
Voevodskaya, N ;
McClarty, G ;
Gräslund, A ;
Nordlund, P .
SCIENCE, 2004, 305 (5681) :245-248
[46]   Synthetic peptides based on Chlamydia trachomatis antigens identify cytotoxic T lymphocyte responses in subjects from a trachoma-endemic population [J].
Holland, MJ ;
Conway, DJ ;
Blanchard, TJ ;
Mahdi, OMS ;
Bailey, RL ;
Whittle, HC ;
Mabey, DCW .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (01) :44-49
[47]   T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); Responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring [J].
Holland, MJ ;
Bailey, RL ;
Conway, DJ ;
Culley, F ;
Miranpuri, G ;
Byrne, GI ;
Whittle, HC ;
Mabey, DCW .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (03) :429-435
[48]  
Igietseme Joseph U, 2003, Expert Rev Vaccines, V2, P129, DOI 10.1586/14760584.2.1.129
[49]  
Igietseme Joseph U, 2004, Expert Rev Vaccines, V3, P23
[50]   Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: Potential for cellular vaccine development [J].
Igietseme, JU ;
Ananaba, GA ;
Bolier, J ;
Bowers, S ;
Moore, T ;
Belay, T ;
Eko, FO ;
Lyn, D ;
Black, CM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4212-4219